Country Grants

View all
View all
View activity

The Country Grants constitute the largest funding envelope across the programme and are focused on building laboratory capacity and establishing surveillance systems within the 24 priority countries.

Funding Priorities

Typical first round country grants are allocated for a period of 12-24 months and funding envelopes differ per country based upon the needs and assessed priorities. In some countries, two rounds of grants will be given. Each RFP differs based on country needs and priorities, as identified in the National Action Plan for AMR but there are five core funding areas:

A typical country grant will seek to support 4-10 human health surveillance sites (1 National Reference Laboratory and clinical laboratories) and 1-3 animal health laboratories (1 National Reference Laboratory and 1-2 regional sites).

In animal health, grants often start in poultry, with additional objectives of surveillance of antimicrobial use and antimicrobial consumption. In human health, clinical microbiology laboratory capacity for blood cultures is developed at key sentinel sites, with a focus on WHO GLASS priority pathogens, taking a passive surveillance approach.

Grant Making Process

The Management Agent, Mott MacDonald undertakes the following grant making process:

Expected Impact

By 2022, the Fleming Fund will have helped 24 low- and middle-income countries to build sustainable national surveillance systems to tackle AMR. The increase in data, shared nationally and globally, will form the basis of changes in policy and practice leading to more optimal use of antimicrobial medicines.

Latest Activity from Country Grants

In partnership with the Fleming Fund, the Royal Government of Bhutan’s Ministry of Health (MoH) has renovated three antimicrobi…

The UK government's Fleming Fund project in Pakistan, led by grantee DAI and managed by Mott MacDonald, won the global antimicrobial…

Inauguration of upgraded national laboratories, supported by the Fleming Fund, UK Health Security Agency and DAI.